Digital Solutions for National Health Records | Accenture The Directorate's goal in creating national health records was to enable health services to interact and collaborate more effectively, along with empowering patients to manage their own health while improving patient safety To achieve their vision, Accenture helped develop and deliver a new digital system making national health records available when and where they’re needed by clinicians
Microsoft Word - DSTI_DOC_2007_7. doc - OECD The Working Paper series of the OECD Directorate for Science, Technology and Industry is designed to make available to a wider readership selected studies prepared by staff in the Directorate or by outside consultants working on OECD projects
Biologics and Radiopharmaceutical Drugs Directorate The Biologics and Radiopharmaceutical Drugs Directorate (BRDD) Annual Drug Submission Performance Report reflects biologic and radiopharmaceutical drug submission review activity over five consecutive fiscal years (April 1 to March 31) from 2017-2018 to 2021-2022
BGTD Drug Submission Performance Annual Report FY 2018-19 The Biologics and Genetic Therapies Directorate’s (BGTD) Annual Drug Submission Performance Report reflects biologic and radiopharmaceutical drug submission review activity over five consecutive fiscal years (April 1 to March 31) from 2014-2015 to 2018-2019